Skip to main content

 News

LONG LIVE SUMMER! Welcome the summer with serenity despite your illness

News (19/03/2025)LONG LIVE SUMMER! 
Welcome the summer with serenity despite your illnessMay 14 and 15 (from 8:30 a.m. to 3:30 p.m. in the lobby of the Jules Bordet Institute)When you have a cancer the arrival of summer can be a source of additional stress. Managing your illness and side effects can be more complicated in the summer months and a source of anxiety: How to manage a stoma when you want to swim? What hair solutions when the…
(read more)

Journée Portes Ouvertes de l'H.U.B

Actualités (17/03/2025) ProgrammeRendez-vousDate : Jeudi 3 avril 2025, de 8h30 à 16h30Lieu : Hôpital Erasme, Route de Lennik 808, 1070 Anderlecht 
Concept4 services ouvrent leurs portes : la cardiologie, la gastro-entérologie, la néphrologie et la neurologie.4 groupes de 10 personnes visitent chacun 2 services sur la journée, 1 le matin et 1 l’après-midi.
(read more)

Blue Marsh : Fast-track diagnosis for colorectal cancer at the H.U.B

Press release (03/05/2025) Fast-track diagnosis for colorectal cancer at the H.U.BBrussels, 3 March 2025 – For more than a year now, the teams at the Gastroenterology and Digestive Oncology Department at the Erasmus Hospital and Jules Bordet Institute have been proposing a new fast-track diagnosis for colorectal cancer. This is exclusively for patients showing warning signs, testing positive for the presence of blood in the stools or…
(read more)

New : Well-being workshops

News (24/02/2025)Need a break from your treatment routine? Come and discover our well-being workshops!Free and open to all, at any stage of your treatment. Workshops are reserved for Bordet patients only. Participation is free, but registration is mandatory. No prior knowledge is required. To register, send an e-mail to :
bien-etre.di@hubruxelles.be
(read more)

World Cancer Day - 2025

News (04/02/2025)On the occasion of World Cancer Day we spoke with Dr Chloé Spilleboudt, head doctor at the Jules Bordet Institute, the integrated cancer centre in Brussels. We discussed the current cancer situation in Belgium, the major challenges in treating the disease and the treatment innovations proposed by the Institute.  Q : Dr Spillebout, can you tell us about the present situation? Research is progressing, screening is more…
(read more)

Progress in leukaemia research

News (27/01/2025)Progress in leukaemia research: when the leukaemia cells reprogramme normal cells remotely...The Clinical Cell Therapy Laboratory at the Jules Bordet Institute –H.U.B,  headed by Professor Laurence Lagneaux, has just taken a major step forward in our understanding of chronic lymphocytic leukaemia, the most common form of the disease in Western countries.  Dr Nathan Dubois and Professor Basile Stamatopoulos have…
(read more)

Une avancée majeure en biologie combine ADN et ARN et pourrait révolutionner les traitements anticancéreux

Communiqué de presse (17/01/2025) Une avancée majeure en biologie combine ADN et ARN et pourrait révolutionner les traitements anticancéreux
Recherche Emmenés par François Fuks - Laboratoire d’Epigénétique du Cancer, Faculté de Médecine ULB, ULB-Cancer Research Center et Institut Jules Bordet, H.U.B. - , des chercheurs découvrent un nouveau mécanisme qui, en combinant l’épigénétique de l’ADN et de l’ARN, permet une régulation…
(read more)

A revolutionary radiotherapy technology: ​ Comprehensive Motion Management (CMM)

Press release (17/12/2024) The Jules Bordet Institute deploys a revolutionary radiotherapy technology: ​ Comprehensive Motion Management (CMM)Brussels, 12/17/2024 – The Jules Bordet Institute is taking a major step forward in becoming one of just 12 centres worldwide to incorporate ​ Comprehensive Motion Management (CMM) in its MR-Linac, a technology at the forefront of radiotherapy.Unequalled precision in the service of patients
Unique…
(read more)

Best wishes 2025 !

Best wishes !We wish you a very happy festive season!Click on the picture to start the video
(read more)

Le programme RESTART accessible aux patients atteints d'un cancer gynécologique

Actualité publiée ce 11/12/2024Le programme RESTART évolue et est désormais accessible pour les patients atteints d'un cancer gynécologique. Depuis deux ans, le programme RESTART s’adresse aux patientes en rémission d’un cancer du sein et ayant terminé les traitements de chimiothérapie, chirurgie et radiothérapie depuis moins de 3 mois et propose un suivi multidisciplinaire et personnalisé intégrant consultation, activités physiques,…
(read more)